These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34813686)

  • 1. The role of complement in the clinical course of hepatocellular carcinoma.
    Qian X; Yang Z; Gao L; Liu Y; Yan J
    Immun Inflamm Dis; 2022 Mar; 10(3):e569. PubMed ID: 34813686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
    Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
    World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
    Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
    Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
    Wu M; Jiang L
    Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Lu J; An SG; Ma JJ; Yang Y; Zhang L; Yu P; Tao H; Chen YF; Zhang HX
    Chin Med Sci J; 2022 Dec; 37(4):331-339. PubMed ID: 36647592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
    Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y
    Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X
    World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CFHR3 is a potential novel biomarker for hepatocellular carcinoma.
    Liu J; Li W; Zhao H
    J Cell Biochem; 2020 Apr; 121(4):2970-2980. PubMed ID: 31709629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma.
    Wu SY; Xie ZY; Yan LY; Liu XF; Zhang Y; Wang DA; Dong J; Sun HT
    BMC Immunol; 2022 Jun; 23(1):28. PubMed ID: 35659256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
    Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
    Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study.
    Chen W; Chen X; Li S; Ren B
    J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the Sixth Complement Component as Potential Key Genes in Hepatocellular Carcinoma via Bioinformatics Analysis.
    Mu D; Qin F; Li B; Zhou Q
    Biomed Res Int; 2020; 2020():7042124. PubMed ID: 33083480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
    Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma.
    Qu LH; Fang Q; Yin T; Yi HM; Mei GB; Hong ZZ; Qiu XB; Zhou R; Dong HF
    Cancer Immunol Immunother; 2022 Oct; 71(10):2449-2467. PubMed ID: 35254477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcript levels of spindle and kinetochore-associated complex 1/3 as prognostic biomarkers correlated with immune infiltrates in hepatocellular carcinoma.
    Yu DC; Chen XY; Li X; Zhou HY; Yu DQ; Yu XL; Hu YC; Zhang RH; Zhang XB; Zhang K; An JD
    Sci Rep; 2021 May; 11(1):11165. PubMed ID: 34045512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
    Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
    Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
    Front Immunol; 2021; 12():780509. PubMed ID: 35069551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.